Verus Capital Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Hold |
4,300
| – | – | 0.03% | 302 |
|
|
2025
Q1 | $312K | Sell |
4,300
-7
| -0.2% | -$507 | 0.03% | 298 |
|
|
2024
Q4 | $319K | Buy |
4,307
+7
| +0.2% | +$518 | 0.03% | 293 |
|
|
2024
Q3 | $284K | Sell |
4,300
-154
| -3% | -$10.2K | 0.03% | 304 |
|
|
2024
Q2 | $411K | Buy |
4,454
+34
| +0.8% | +$3.14K | 0.04% | 231 |
|
|
2024
Q1 | $422K | Hold |
4,420
| – | – | 0.05% | 212 |
|
|
2023
Q4 | $337K | Buy |
4,420
+59
| +1% | +$4.5K | 0.04% | 223 |
|
|
2023
Q3 | $302K | Hold |
4,361
| – | – | 0.04% | 221 |
|
|
2023
Q2 | $411K | Sell |
4,361
-29
| -0.7% | -$2.74K | 0.06% | 186 |
|
|
2023
Q1 | $363K | Buy |
4,390
+3
| +0.1% | +$248 | 0.06% | 198 |
|
|
2022
Q4 | $327K | Buy |
4,387
+57
| +1% | +$4.25K | 0.06% | 197 |
|
|
2022
Q3 | $358K | Buy |
4,330
+2,977
| +220% | +$246K | 0.07% | 187 |
|
|
2022
Q2 | $414K | Sell |
1,353
-2,967
| -69% | -$908K | 0.08% | 179 |
|
|
2022
Q1 | $434K | Buy |
+4,320
| New | +$434K | 0.07% | 207 |
|
|
2020
Q1 | $277K | Sell |
4,410
-300
| -6% | -$18.8K | 0.09% | 144 |
|
|
2019
Q4 | $366K | Buy |
+4,710
| New | +$366K | 0.12% | 133 |
|